Mirador Capital Partners’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-40,475
Closed -$1.33M 203
2022
Q2
$1.33M Sell
40,475
-30,968
-43% -$1.01M 0.31% 63
2022
Q1
$1.88M Buy
71,443
+1,535
+2% +$40.4K 0.38% 61
2021
Q4
$1.66M Buy
69,908
+8,842
+14% +$210K 0.35% 68
2021
Q3
$1.53M Buy
61,066
+4,040
+7% +$101K 0.35% 70
2021
Q2
$1.48M Buy
57,026
+209
+0.4% +$5.43K 0.34% 74
2021
Q1
$1.46M Buy
56,817
+16,768
+42% +$429K 0.37% 73
2020
Q4
$803K Buy
40,049
+3,041
+8% +$61K 0.22% 98
2020
Q3
$634K Buy
37,008
+17,275
+88% +$296K 0.2% 100
2020
Q2
$431K Buy
19,733
+1,286
+7% +$28.1K 0.16% 98
2020
Q1
$427K Sell
18,447
-4,004
-18% -$92.7K 0.18% 89
2019
Q4
$741K Buy
22,451
+493
+2% +$16.3K 0.3% 80
2019
Q3
$699K Buy
21,958
+10,223
+87% +$325K 0.31% 78
2019
Q2
$301K Buy
11,735
+1,258
+12% +$32.3K 0.15% 115
2019
Q1
$266K Buy
10,477
+2,097
+25% +$53.2K 0.14% 117
2018
Q4
$285K Sell
8,380
-954
-10% -$32.4K 0.18% 102
2018
Q3
$333K Buy
9,334
+2,063
+28% +$73.6K 0.16% 110
2018
Q2
$251K Sell
7,271
-251
-3% -$8.67K 0.14% 120
2018
Q1
$249K Sell
7,522
-41,447
-85% -$1.37M 0.17% 104
2017
Q4
$1.87M Sell
48,969
-451
-0.9% -$17.2K 1.02% 36
2017
Q3
$1.89M Buy
49,420
+868
+2% +$33.2K 1.11% 31
2017
Q2
$1.69M Buy
48,552
+17,618
+57% +$615K 1.04% 31
2017
Q1
$1.21M Buy
30,934
+3,127
+11% +$123K 0.88% 38
2016
Q4
$968K Sell
27,807
-108
-0.4% -$3.76K 0.78% 44
2016
Q3
$1.1M Buy
27,915
+20,870
+296% +$820K 0.96% 42
2016
Q2
$271K Buy
+7,045
New +$271K 0.27% 84